GT Biopharma, Inc. (GTBP)
Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
0. 33
+0.01
+3.1173%
$
3.67M Market Cap
- P/E Ratio
- Div Yield
366,399 Volume
-10.8 Eps
$ 0.32
Previous Close 
Want to track GTBP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
GT Biopharma (GTBP) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
GT Biopharma (GTBP) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Zacks | 4 months ago
What made GT Biopharma stock more than double on Monday?
GT Biopharma Inc (NASDAQ: GTBP) is up a whopping 150% at writing even though there hasn't been any news to catalyse that sort of a rally in shares of the clinical-stage biopharmaceutical company.
Invezz | 2 years ago
Why Is GT Biopharma (GTBP) Stock Up 143% Today?
GT Biopharma (NASDAQ: GTBP ) stock is soaring higher on Monday alongside heavy pre-market trading of the clinical-stage biopharmaceutical company's shares. This has more than 10.6 million shares of GTBP stock changing hands as of this writing.
Investorplace | 2 years ago
